Abstract:Background/aim: Dysautonomia appears in almost all patients with Parkinson's disease (PD) in a certain stage of their condition. The aim of our study was to detect the development and type of autonomic disorders, find out the factors affecting their manifestation by analyzing the potential association with demographic variables related to clinical presentation, as well as the symptoms of the disease in a PD patient cohort. Methods: The patients with PD treated at the Clinic of Neurology in Belgrade during a 2-year period, divided into 3 groups were studied: 25 de novo patients, 25 patients already treated and had no long-term levodopa therapy-related complications and 22 patients treated with levodopa who manifested levodopa-induced motor complications. Simultaneously, 35 healthy control subjects, matched by age and sex, were also analyzed. Results: Autonomic nervous system malfunction was defined by Ewing diagnostic criteria. The tests, indicators of sympathetic and parasympathetic nervous systems, were significantly different in the PD patients as compared with the controls, suggesting the failure of both systems. However, it was shown, in the selected groups of patients, that the malfunction of both systems was present in two treated groups of PD patients, while de novo group manifested only sympathetic dysfunction. For this reason, the complete autonomic neuropathy was diagnosed only in the treated PD patients, while de novo patients were defined as those with the isolated sympathetic dysfunction. The patients with the complete autonomic neuropathy differed from the subjects without such neuropathy in higher cumulative and motor unified Parkinson's disease rating score (UPDRS) (p < 0.01), activities of daily living scores (p < 0.05), Schwab-England scale (p < 0.001) and Hoehn-Yahr scale. There was no difference between the patients in other clinical-demographic characteristics (sex, age at the time of diagnosis, actual age, duration of disease, involved side of the body, pain and freezing), but mini mental status (MMS) score and Hamilton depression and anxiety rating scale were significantly lower (p < 0.05). Conclusion: Our results confirm a high prevalence of autonomic nervous system disturbances among PD patients from the near onset of disease, with a predominant sympathetic nervous system involvement. The patients who developed complete autonomic neuropathy (both sympathetic and parasympathetic) were individuals with considerable level of functional failure, more severe clinical presentation and the existing anxiety and depression.

Chronotropic Incompetence in Parkinson's Disease: A Possible Marker of Severe Disease Phenotype?

Autonomic Function and Motor Subtypes in Parkinson’s Disease: a Multicentre Cross-Sectional Study

Chronotropic Incompetence During Exercise Testing as a Marker of Autonomic Dysfunction in Individuals with Early Parkinson's Disease

Cardiovascular Autonomic Dysfunction is Associated with Executive Dysfunction and Poorer Quality of Life in Progressive Supranuclear Palsy-Richardson’s Syndrome

The effect of chronotropic incompetence on physiologic responses during progressive exercise in people with Parkinson’s disease

Chronotropic Incompetence across Heart Failure Categories

Cytokine and Chemokine Map of Peripheral Specific Immune Cell Subsets in Parkinson's Disease

Locus Coeruleus Degeneration Correlated with Levodopa Resistance in Parkinson's Disease: A Retrospective Analysis.

O065 Autonomic Dysregulation During Sleep in Parkinsonian Spectrum Disorders

Central Nervous System-Derived Exosomal Alpha-Synuclein in Serum May Be a Biomarker in Parkinson's Disease.

Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease

Assessment of Autonomic Dysfunction in Patients with Parkinson's Disease

Chronotropic incompetence as a critical predictor for cardiovascular outcomes in heart failure with preserved ejection function

Autonomic dysregulation during sleep in Parkinsonian spectrum disorders - A proof of concept

When do the symptoms of autonomic nervous system malfunction appear in patients with Parkinson's disease?

Impaired circadian heart rate variability in Parkinson’s disease: a time-domain analysis in ambulatory setting

Estimating motor progression trajectory pursuant to temporal dynamic status of cardiac denervation in Parkinson's disease

Monoaminergic degeneration, cognition, and autonomic symptom trajectory in early Parkinson's disease

Autonomic symptoms in early-stage Parkinson’s patients and their relationship with cognition and disease parameters

Clinical Feasibility of a New Method to Identify Chronotropic Incompetence in Heart Failure Patients.

Decreased Heart Rate Variability in Sympathetic Dominant States in Parkinson's Disease and Isolated REM Sleep Behavior Disorder